Navigation Links
Global In Vitro Diagnostic Market Analysis
Date:12/15/2011

NEW YORK, Dec. 15, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Global In Vitro Diagnostic Market Analysis

http://www.reportlinker.com/p0444456/Global-In-Vitro-Diagnostic-Market-Analysis.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=In_Vitro_Diagnostic

With the rapidly diversifying diagnostic industry, the In Vitro Diagnostic (IVD) has evolved as a major contributing segment. Extensive scientific research and development, technological advancements, and rising government and private sector participation are facilitating the growth globally. Demographic parameters, such as increasing disease prevalence and high disposable income have also contributed to the development of IVD services industry, which was estimated to have reached around US$ 43 Billion in 2010.

According to our new research report "Global In Vitro Diagnostic Market Analysis", the global IVD market is likely to grow at a CAGR of around 6% during 2011-2013 to reach around US$ 52 Billion by 2013-end. The industry, which has been witnessing innovative healthcare and diagnostic solutions, is anticipated to continue striving towards technological innovation and widening its spectrum in all dimensions.

The report analyzes the key segments in the IVD market, which has witnessed tremendous growth in the recent years. The developments in the point-of-care and molecular diagnostics segment are also found to be high. The research also observes that the increasing prevalence of chronic diseases and rising technological R&D are fuelling growth in these segments. It also studies how the rising healthcare spending across the globe would impact these segments, which are likely to witness robust growth in revenues.

Our report provides a comprehensive geographic segmentation of the IVD market globally. Through top countries' profiles, the study elaborates the performance of the IVD market in these nations, key developments in recent times, and provides forecast for the industry. The developed countries have been performing well in the IVD industry, but a great potential also lies for the industry in developing countries.

The report finds that Companion Diagnostics and Nano-diagnostics are the emerging sectors in the IVD industry, in which the growth is being fuelled by extensive R&D and novel solutions. The report also discusses the profiles of the key players in the industry to provide an insight into the competitive landscape.

1. Analyst View

2. Research Methodology

3. In Vitro Diagnostic Market Overview

3.1 Introduction

3.2 What is In Vitro Diagnostics?

3.3 Market Size and Growth

4. Market Drivers

4.1 Chronic and Infectious Diseases

4.2 New Technologies

4.3 Emerging Markets

4.4 Diversifying Applications

4.5 Healthcare Infrastructure

5. Clinical Segmentation Outlook 2013

5.1 Point-of-Care Diagnostics

5.2 Clinical Chemistry and Immunochemistry

5.3 Molecular Diagnostics

5.4 Microbiology

5.5 Hemostasis

5.6 Hematology

5.7 Immunohematology

6. Segmentation by Indication (Current & Future Scenario - 2013)

6.1 Diabetes

6.2 Cardiovascular

6.3 Cancer

6.4 HIV

6.5 Tuberculosis

6.6 Influenza

7. Geographical Segmentation (Current & Future Scenario - 2013)

7.1 North America

7.1.1 United States

7.1.2 Canada

7.2 Europe

7.2.1 Germany

7.2.2 France

7.2.3 Italy

7.2.4 United Kingdom

7.2.5 Spain

7.2.6 Other European Countries

7.3 Japan

7.4 Other Key Countries

7.4.1 China

7.4.2 India

7.4.3 Turkey

7.4.4 Brazil

7.4.5 Mexico

8. Consumer Behavior Analysis

9. Emerging Sectors

9.1 Companion Diagnostics/Theranostics

9.2 Nanodiagnostics

10. Recent Developments and M&As

11. Industry Restraints

11.1 Regulatory and Reimbursement Issues

11.2 R&D and Short Product Lifecycle

11.3 Cost Control

12. Competitive Landscape

12.1 Market Share of Top Players

12.2 Key Players

12.2.1 Roche Holding Ltd.

12.2.2 Abbott Laboratories

12.2.3 Siemens AG

12.2.4 Beckman Coulter

12.2.5 Ortho-Clinical Diagnostics

List of Figures:

Figure 3-1: Global - In Vitro Diagnostic Market (Billion US$), 2008-2013

Figure 5-1: Global - In Vitro Diagnostic Market by Clinical Segment (%), 2010

Figure 5-2: Global - Forecast for In Vitro Diagnostic Market by Clinical Segment (%), 2013

Figure 5-3: Global - Point of Care Diagnostic Market by Segment (%)

Figure 5-4: Global - Point of Care Diagnostic Market by Distribution (%)

Figure 5-5: Global - Point of Care Diagnostic Market (Billion US$), 2009-2013

Figure 5-6: Global - Clinical Chemistry & Immunochemistry Market (Billion US$), 2009-2013

Figure 5-7: Global - Share of Players in Molecular Diagnostic Market (2010)

Figure 5-8: Global - Molecular Diagnostic Market (Billion US$), 2009-2013

Figure 5-9: Global - Microbiology Diagnostic Market (Billion US$), 2010-2013

Figure 5-10: Global - Hemostasis Diagnostic Market (Billion US$), 2010-2013

Figure 5-11: Global - Hematology Market (Billion US$), 2009-2013

Figure 5-12: Global - Immunohematology Diagnostic Market (Billion US$), 2009-2013

Figure 6-1: Global - Diabetic Population (Million), 2010 & 2030

Figure 6-2: Global - Diabetes Diagnostic & Therapies Market (Billion US$), 2009-2013

Figure 6-3: Global - Cardiovascular Diagnostic and Therapies Market (Billion US$), 2009-2013

Figure 6-4: Global - Cancer In Vitro Diagnostic Market (Billion US$), 2011-2013

Figure 6-5: Global - HIV Diagnostic and Monitoring Market (Million US$), 2004, 2008 & 2012

Figure 6-6: Global - Tuberculosis Diagnostic Market by Segment (%)

Figure 6-7: Global - Tuberculosis Detection and Monitoring Market by Segment (%)

Figure 6-8: Global - Influenza Diagnostic Market (Million US$), 2008-2013

Figure 7-1: Global - In Vitro Diagnostic Market by Region (%), 2010

Figure 7-2: Global - Forecast for In Vitro Diagnostic Market by Region (%), 2013

Figure 7-3: US - Labs in IVD Market by Type (%)

Figure 7-4: US - In Vitro Diagnostic Market (Billion US$), 2008-2013

Figure 7-5: Canada - In Vitro Diagnostic Market (Billion US$), 2009-2013

Figure 7-6: Europe - In Vitro Diagnostic Market (Billion Euro), 2009-2013

Figure 7-7: Europe - In Vitro Diagnostic Market by Country (%), 2009

Figure 7-8: Germany - In Vitro Diagnostic Market by Clinical Segment (%), 2009

Figure 7-9: Germany - In Vitro Diagnostic Market (Billion Euro), 2009-2013

Figure 7-10: France - In Vitro Diagnostic Reagents Market by Clinical Segment (%)

Figure 7-11: France - In Vitro Diagnostic Market (Billion Euro), 2009-2013

Figure 7-12: Italy - In Vitro Diagnostic Market by Segment (%), 2008

Figure 7-13: Italy - In Vitro Diagnostic Reagents Market by Segment (%), 2008

Figure 7-14: Italy - In Vitro Diagnostic Market (Billion Euro), 2009-2013

Figure 7-15: UK - In Vitro Diagnostic Market by Clinical Segment (%), 2009

Figure 7-16: UK - In Vitro Diagnostic Market (Billion Euro), 2009-2013

Figure 7-17: Spain - In Vitro Diagnostic Market (Billion Euro), 2009-2013

Figure 7-18: Japan - In Vitro Diagnostic Market by Clinical Segment (%), 2009

Figure 7-19: Japan - Share of Players in In Vitro Diagnostic Market

Figure 7-20: Japan - In Vitro Diagnostic Market (Billion Yen), 2009-2013

Figure 7-21: China - In Vitro Diagnostic Market by Clinical Segment (%), 2009

Figure 7-22: China - In Vitro Diagnostic Market (Billion US$), 2009-2013

Figure 7-23: India - In Vitro Diagnostic Market by Clinical Segment (%), 2009

Figure 7-24: India - In Vitro Diagnostic Market (Million US$), 2009-2013

Figure 7-25: Turkey - Share of Clinical Laboratories by Type

Figure 7-26: Turkey - In Vitro Diagnostic Market (Million Euro), 2008-2013

Figure 7-27: Brazil - In Vitro Diagnostic Market by Clinical Segment (%), 2009

Figure 7-28: Brazil - In Vitro Diagnostic Market (Million US$), 2009-2013

Figure 7-29: Mexico - In Vitro Diagnostic Market by Clinical Segment (%)

Figure 7-30: Mexico - In Vitro Diagnostic Market (Million US$), 2008-2013

Figure 11-1: Global - R&D Expenditure on IVD in Comparison to Other Industrial Sectors (%)

Figure 12-1: Global - Share of Players in In Vitro Diagnostic Market

Figure 12-2: Roche Holding Ltd. - Diagnostic Division Revenues by Segment (%), 2010

Figure 12-3: Abbott Laboratories - Diagnostic Products Sales (Million US$), 2007-2010

Figure 12-4: Siemens AG - Diagnostic Division Revenues (Million Euro), FY 2009 & FY 2010

Figure 12-5: Beckman Coulter - Clinical Diagnostics Revenues by Segment (%), 2010

List of Tables:

Table 3-1: Commonly Used In Vitro and In Vivo Diagnostic Tests

Table 5-1: Global - In Vitro Diagnostic Market by Clinical Segment (Billion US$), 2010

Table 5-2: Global - Forecast for In Vitro Diagnostic Market by Clinical Segment (Billion US$), 2013

Table 5-3: Global - Share of Top Players in Clinical Chemistry and Immunochemistry Market (2010)

Table 5-4: Global - Share of Top Players in Microbiology Diagnostic Market (2010)

Table 5-5: Global - Share of Top Players in Hemostasis Diagnostic Market (2009)

Table 6-1: Global - Leading Companies in Diabetes Equipment Sales (Billion US$)

Table 7-1: Other European Countries - In Vitro Diagnostic Market (Million Euro), 2009

Table 12-1: Roche Holding Ltd. - Strengths & Weaknesses

Table 12-2: Abbott Laboratories - Strengths & Weaknesses

Table 12-3: Siemens AG - Strengths & Weaknesses

Table 12-4: Beckman Coulter - Strengths & Weaknesses

Table 12-5: Ortho-Clinical Diagnostics - Strengths & Weaknesses

To order this report:

In Vitro Diagnostic Industry: Global In Vitro Diagnostic Market Analysis

More  Market Research Report

Check our  Industry Analysis and Insights

CONTACT
Nicolas Bombourg
Reportlinker
Email: nbo@reportlinker.com
US: (805)652-2626
Intl: +1 805-652-2626


'/>"/>
SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Novocure Adds Three Senior Oncology Executives to its Global Management Team
2. Global Sterilization Equipment and Supplies Industry
3. Global Hospital Information Systems (HIS) Industry
4. Helping Companies Reach Global Markets
5. Global Medical Ultrasound Equipment Industry
6. Global Respiratory Care Equipment And Supplies Industry
7. Global Gamma/Scintillation Cameras Industry
8. Global Magnetic Resonance Imaging (MRI) Equipment Industry
9. Global Pulse Oximeters Industry
10. Global Coronary Stents Industry
11. Global Endoscopy Systems Industry
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... CHAPEL HILL, N.C. , June 24, 2016 ... in healthcare decisions and regulators/payers have placed more ... this new environment, patient support programs in the ... support for patients, medications. Consequently, pharmaceutical companies are ... to ensure they are providing products and services ...
(Date:6/24/2016)...   Bay Area Lyme Foundation , collaborating ... for Tick Borne Illness , Harvard Medical School ... Medicine, University of California, Berkeley, and the Veterans ... finalists of Lyme Innovation , the first ... scientists, clinicians, researchers, entrepreneurs, and investors from several ...
(Date:6/24/2016)... -- The Academy of Managed Care Pharmacy (AMCP) today ... allow biopharmaceutical companies to more easily share health care ... coverage decisions, a move that addresses the growing need ... The recommendations address restrictions in the sharing of product ... a prohibition that hinders decision makers from accessing HCEI ...
Breaking Medicine Technology:
(Date:6/27/2016)... , ... June 27, 2016 ... ... the patient payment industry today announced its strategic partnership with Connance, a ... workflows. , The two companies’ proven, proprietary technology combine to provide health ...
(Date:6/26/2016)... ... June 27, 2016 , ... Quality metrics are proliferating ... many ways they remain in the eye of the beholder, according to experts who ... of The American Journal of Managed Care. For the full issue, click here ...
(Date:6/26/2016)... ... , ... PawPaws brand pet supplements owned by Whole Health Supply ... health of felines. The formula is all-natural and is made from Chinese herbs that ... Cat Kidney Support Supplement Soft Chews are Astragalus Root Extract and Rehmannia Root ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... ... health policy issues and applications at AcademyHealth’s Annual Research Meeting June 26-28, 2016, ... work on several important health care topics including advance care planning, healthcare costs ...
(Date:6/25/2016)... , ... June 25, 2016 , ... "With 30 hand-drawn ... specific project," said Christina Austin - CEO of Pixel Film Studios. , ProHand ... all within Final Cut Pro X . Simply select a ProHand generator and ...
Breaking Medicine News(10 mins):